Comparison of platelet-rich plasma formulations for cartilage healing: An in vitro study

Carola Cavallo, Giuseppe Filardo, Erminia Mariani, Elizaveta Kon, Maurilio Marcacci, Maria Teresa Pereira Ruiz, Andrea Facchini, Brunella Grigolo

Research output: Contribution to journalArticle

91 Citations (Scopus)

Abstract

Background: Platelet-rich plasma (PRP) has been advocated as one treatment for cartilage tissue regeneration. To date, several different platelet-rich formulations have been available, but a deep knowledge of their composition and mechanism of action in a specific clinical use is needed. The aim of this study was to investigate the effect of various PRP formulations on human chondrocytes in vitro. Methods: Blood from ten human volunteers was used to prepare three formulations: (1) PRP with a relatively low concentration of platelets and very few leukocytes (P-PRP), (2) PRP with high concentrations of both platelets and leukocytes (L-PRP), and (3) platelet-poor plasma (PPP). Selected growth factors in the formulations were measured, and the in vitro effects of various concentrations were tested by exposing chondrocytes isolated from osteoarthritic cartilage of four different men and measuring cell proliferation, matrix production, and gene expression. Results: L-PRP contained the highest levels of growth factors and cytokines. All three formulations stimulated chondrocyte proliferation throughout the culture period evaluated; the only significant difference among the formulations was on day 7, when P-PRP induced greater cell growth compared with the other two formulations. P-PRP stimulated chondrocyte anabolism, as shown by the expression of type-II collagen and aggrecan, whereas L-PRP promoted catabolic pathways involving various cytokines. However, L-PRP induced greater expression of the hyaluronic acid synthase-2 gene and greater production of hyaluronan compared with P-PRP. Conclusions: L-PRP and P-PRP induced distinct effects on human articular chondrocytes in vitro, possibly because of differences in the concentrations of platelets, leukocytes, growth factors, and other bioactive molecules. The identification of the optimal amounts and ratios of these blood components could ideally lead to a formulation more suitable for the treatment of cartilage lesions. Clinical Relevance: PRP formulations that are suitable for the treatment of degenerative joint diseases will likely contain balanced concentrations of platelets and leukocytes.

Original languageEnglish
Pages (from-to)423-429
Number of pages7
JournalJournal of Bone and Joint Surgery - Series A
Volume96
Issue number5
DOIs
Publication statusPublished - Mar 5 2014

Fingerprint

Platelet-Rich Plasma
Cartilage
Chondrocytes
Blood Platelets
Leukocytes
Intercellular Signaling Peptides and Proteins
In Vitro Techniques
Hyaluronic Acid
Cytokines
Aggrecans
Collagen Type II
Osteoarthritis

ASJC Scopus subject areas

  • Surgery
  • Orthopedics and Sports Medicine

Cite this

Comparison of platelet-rich plasma formulations for cartilage healing : An in vitro study. / Cavallo, Carola; Filardo, Giuseppe; Mariani, Erminia; Kon, Elizaveta; Marcacci, Maurilio; Pereira Ruiz, Maria Teresa; Facchini, Andrea; Grigolo, Brunella.

In: Journal of Bone and Joint Surgery - Series A, Vol. 96, No. 5, 05.03.2014, p. 423-429.

Research output: Contribution to journalArticle

Cavallo, Carola ; Filardo, Giuseppe ; Mariani, Erminia ; Kon, Elizaveta ; Marcacci, Maurilio ; Pereira Ruiz, Maria Teresa ; Facchini, Andrea ; Grigolo, Brunella. / Comparison of platelet-rich plasma formulations for cartilage healing : An in vitro study. In: Journal of Bone and Joint Surgery - Series A. 2014 ; Vol. 96, No. 5. pp. 423-429.
@article{67ce7b7d0fd744d38ff98ff66de32aec,
title = "Comparison of platelet-rich plasma formulations for cartilage healing: An in vitro study",
abstract = "Background: Platelet-rich plasma (PRP) has been advocated as one treatment for cartilage tissue regeneration. To date, several different platelet-rich formulations have been available, but a deep knowledge of their composition and mechanism of action in a specific clinical use is needed. The aim of this study was to investigate the effect of various PRP formulations on human chondrocytes in vitro. Methods: Blood from ten human volunteers was used to prepare three formulations: (1) PRP with a relatively low concentration of platelets and very few leukocytes (P-PRP), (2) PRP with high concentrations of both platelets and leukocytes (L-PRP), and (3) platelet-poor plasma (PPP). Selected growth factors in the formulations were measured, and the in vitro effects of various concentrations were tested by exposing chondrocytes isolated from osteoarthritic cartilage of four different men and measuring cell proliferation, matrix production, and gene expression. Results: L-PRP contained the highest levels of growth factors and cytokines. All three formulations stimulated chondrocyte proliferation throughout the culture period evaluated; the only significant difference among the formulations was on day 7, when P-PRP induced greater cell growth compared with the other two formulations. P-PRP stimulated chondrocyte anabolism, as shown by the expression of type-II collagen and aggrecan, whereas L-PRP promoted catabolic pathways involving various cytokines. However, L-PRP induced greater expression of the hyaluronic acid synthase-2 gene and greater production of hyaluronan compared with P-PRP. Conclusions: L-PRP and P-PRP induced distinct effects on human articular chondrocytes in vitro, possibly because of differences in the concentrations of platelets, leukocytes, growth factors, and other bioactive molecules. The identification of the optimal amounts and ratios of these blood components could ideally lead to a formulation more suitable for the treatment of cartilage lesions. Clinical Relevance: PRP formulations that are suitable for the treatment of degenerative joint diseases will likely contain balanced concentrations of platelets and leukocytes.",
author = "Carola Cavallo and Giuseppe Filardo and Erminia Mariani and Elizaveta Kon and Maurilio Marcacci and {Pereira Ruiz}, {Maria Teresa} and Andrea Facchini and Brunella Grigolo",
year = "2014",
month = "3",
day = "5",
doi = "10.2106/JBJS.M.00726",
language = "English",
volume = "96",
pages = "423--429",
journal = "Journal of Bone and Joint Surgery - Series A",
issn = "0021-9355",
publisher = "Journal of Bone and Joint Surgery Inc.",
number = "5",

}

TY - JOUR

T1 - Comparison of platelet-rich plasma formulations for cartilage healing

T2 - An in vitro study

AU - Cavallo, Carola

AU - Filardo, Giuseppe

AU - Mariani, Erminia

AU - Kon, Elizaveta

AU - Marcacci, Maurilio

AU - Pereira Ruiz, Maria Teresa

AU - Facchini, Andrea

AU - Grigolo, Brunella

PY - 2014/3/5

Y1 - 2014/3/5

N2 - Background: Platelet-rich plasma (PRP) has been advocated as one treatment for cartilage tissue regeneration. To date, several different platelet-rich formulations have been available, but a deep knowledge of their composition and mechanism of action in a specific clinical use is needed. The aim of this study was to investigate the effect of various PRP formulations on human chondrocytes in vitro. Methods: Blood from ten human volunteers was used to prepare three formulations: (1) PRP with a relatively low concentration of platelets and very few leukocytes (P-PRP), (2) PRP with high concentrations of both platelets and leukocytes (L-PRP), and (3) platelet-poor plasma (PPP). Selected growth factors in the formulations were measured, and the in vitro effects of various concentrations were tested by exposing chondrocytes isolated from osteoarthritic cartilage of four different men and measuring cell proliferation, matrix production, and gene expression. Results: L-PRP contained the highest levels of growth factors and cytokines. All three formulations stimulated chondrocyte proliferation throughout the culture period evaluated; the only significant difference among the formulations was on day 7, when P-PRP induced greater cell growth compared with the other two formulations. P-PRP stimulated chondrocyte anabolism, as shown by the expression of type-II collagen and aggrecan, whereas L-PRP promoted catabolic pathways involving various cytokines. However, L-PRP induced greater expression of the hyaluronic acid synthase-2 gene and greater production of hyaluronan compared with P-PRP. Conclusions: L-PRP and P-PRP induced distinct effects on human articular chondrocytes in vitro, possibly because of differences in the concentrations of platelets, leukocytes, growth factors, and other bioactive molecules. The identification of the optimal amounts and ratios of these blood components could ideally lead to a formulation more suitable for the treatment of cartilage lesions. Clinical Relevance: PRP formulations that are suitable for the treatment of degenerative joint diseases will likely contain balanced concentrations of platelets and leukocytes.

AB - Background: Platelet-rich plasma (PRP) has been advocated as one treatment for cartilage tissue regeneration. To date, several different platelet-rich formulations have been available, but a deep knowledge of their composition and mechanism of action in a specific clinical use is needed. The aim of this study was to investigate the effect of various PRP formulations on human chondrocytes in vitro. Methods: Blood from ten human volunteers was used to prepare three formulations: (1) PRP with a relatively low concentration of platelets and very few leukocytes (P-PRP), (2) PRP with high concentrations of both platelets and leukocytes (L-PRP), and (3) platelet-poor plasma (PPP). Selected growth factors in the formulations were measured, and the in vitro effects of various concentrations were tested by exposing chondrocytes isolated from osteoarthritic cartilage of four different men and measuring cell proliferation, matrix production, and gene expression. Results: L-PRP contained the highest levels of growth factors and cytokines. All three formulations stimulated chondrocyte proliferation throughout the culture period evaluated; the only significant difference among the formulations was on day 7, when P-PRP induced greater cell growth compared with the other two formulations. P-PRP stimulated chondrocyte anabolism, as shown by the expression of type-II collagen and aggrecan, whereas L-PRP promoted catabolic pathways involving various cytokines. However, L-PRP induced greater expression of the hyaluronic acid synthase-2 gene and greater production of hyaluronan compared with P-PRP. Conclusions: L-PRP and P-PRP induced distinct effects on human articular chondrocytes in vitro, possibly because of differences in the concentrations of platelets, leukocytes, growth factors, and other bioactive molecules. The identification of the optimal amounts and ratios of these blood components could ideally lead to a formulation more suitable for the treatment of cartilage lesions. Clinical Relevance: PRP formulations that are suitable for the treatment of degenerative joint diseases will likely contain balanced concentrations of platelets and leukocytes.

UR - http://www.scopus.com/inward/record.url?scp=84896369299&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896369299&partnerID=8YFLogxK

U2 - 10.2106/JBJS.M.00726

DO - 10.2106/JBJS.M.00726

M3 - Article

C2 - 24599205

AN - SCOPUS:84896369299

VL - 96

SP - 423

EP - 429

JO - Journal of Bone and Joint Surgery - Series A

JF - Journal of Bone and Joint Surgery - Series A

SN - 0021-9355

IS - 5

ER -